Consensus DexCom, Inc. Sao Paulo

Stocks

D1EX34

BRD1EXBDR004

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo 06:31:00 19/10/2026 pm IST			5-day change	1st Jan Change
8.570 ^BRL	-7.95%		+1.06%	+14.42%

16/10	HEALTH ROUNDS-Glucose monitoring devices for type 2 diabetes benefit even those not on insulin	RE
15/10	DexCom, Inc. Announces Publication Of CONNECT Study Results For Dexcom G7 In The New England Journal Of Medicine	CI

6ac3f0e7965526d43de0a081.10QRdqtXXQMIK_pZU5Jbz0eifOyf_53lIp4HTr9rj-4.5yNaQt8SHzBpT7grEM0x_iDMEZiuudefd9pXOOUdwKuzAVNE8TEtLmVCyg~691e8dea32a4ef950b2fd9e443b1c391

Analysts' recommendations: DexCom, Inc.

13/10	Mizuho Adjusts Price Target on DexCom to $100 From $95	MT
12/10	BTIG Adjusts Price Target on DexCom to $96 From $90	MT
07/10	Evercore ISI Adjusts Price Target on DexCom to $110 From $90	MT
01/10	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
17/09	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
13/08	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
04/08	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
03/08	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
03/08	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
31/07	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
31/07	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
31/07	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
31/07	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
31/07	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
31/07	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
31/07	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
31/07	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
31/07	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
31/07	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
31/07	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
31/07	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
31/07	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
31/07	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
31/07	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
31/07	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
DEXCOM, INC.	-	-	-	-
ABBOTT LABORATORIES				+15.09%
MEDTRONIC PLC				+10.41%
STRYKER CORPORATION				+23.06%
ESSILORLUXOTTICA				+43.42%
CENCORA, INC.				+7.85%
HOYA CORPORATION				+16.96%
BECTON, DICKINSON AND COMPANY				+1.21%
IDEXX LABORATORIES, INC.				+25.9%
DEXCOM, INC.				+12.11%
Average				+17.33%
Weighted average by Cap.				+17.67%